The New Numbers

The CDC released updated provisional data on May 13, 2026: approximately 70,000 Americans died of drug overdoses in 2025, down from more than 81,000 in 2024. That's a 14% drop in a single year.

This is the third consecutive annual decline. Overdose deaths peaked at 110,000 in 2022 — a catastrophic surge driven by the COVID-19 pandemic, social isolation, and gutted treatment access. The country has clawed back roughly 40,000 deaths since that peak.

But seven states bucked the national trend. Arizona, Colorado, and New Mexico each saw overdose deaths increase by 10% or more in 2025, according to CDC data.

What Trump Is Claiming

The White House is pointing to the decline as proof that its enforcement strategy is working.

US Customs and Border Protection announced that in 2026 alone, agents along the southwest border have already seized enough fentanyl to kill more than 100 million Americans. FBI Director Kash Patel posted on social media that his agency seized enough fentanyl to kill more than 200 million Americans across 2025 and 2026 combined.

Attorney General Pam Bondi claimed the administration saved 119 million lives during Trump's first 100 days. The specific figure lacks independent verification.

The administration's policy moves include designating drug cartels as Foreign Terrorist Organizations, classifying fentanyl and its precursor chemicals as Weapons of Mass Destruction, and authorizing military operations against suspected drug trafficking vessels. In January 2026, the Senate confirmed Sara Carter as director of the Office of National Drug Control Policy.

Carter told the Daily Signal that ONDCP has issued new drug threat notices on medetomidine and cychlorphine — two emerging substances now entering the illicit drug supply. Pennsylvania, a state with historically high overdose rates, saw deaths drop 60% in 2025, according to the Daily Signal.

What Public Health Advocates Are Claiming

The Drug Policy Alliance and independent researchers point to several non-enforcement factors in the decline: naloxone now available over the counter and distributed through public health funding, fentanyl test strips becoming mainstream, and expanded access to medications like methadone and buprenorphine that cut overdose risk in half.

Dr. Sheila Vakharia, Deputy Director of Research at the Drug Policy Alliance, cited these factors as central to the decline. Brandon Marshall, a Brown University researcher who studies overdose trends, told the Associated Press he is "cautiously optimistic that this represents a fundamental change in the arc of the overdose crisis," crediting the wider availability of naloxone.

There's also a demographic component: tens of thousands of the most vulnerable users have already died. Fewer people using street fentanyl means fewer people at risk of dying from it.

What Both Sides Are Getting Wrong

The Trump administration is overselling its role. Border seizures prevent some supply from entering, but fentanyl is so potent and easy to smuggle in tiny quantities that interdiction alone cannot explain a 14% national decline. The naloxone expansion, largely funded by opioid settlement money and pre-existing federal grants, deserves significant credit. That work started under previous administrations.

The harm reduction advocates are underselling enforcement. Cartel disruption and supply pressure matter. China limiting precursor chemical exports — which both the Trump administration and researchers acknowledge — has materially constrained production.

Al Jazeera's coverage emphasized harm reduction experts and framed Trump administration claims skeptically. The Daily Signal emphasized Trump wins while minimizing structural public health factors.

New Threats on the Horizon

ONDCP Director Sara Carter flagged medetomidine and cychlorphine as new threats entering the drug supply. A drug 10 times stronger than fentanyl is on the horizon. The warning is being overshadowed by the broader policy debate.

Seventy thousand deaths occurred in 2025 alone. The progress is measurable, but the next wave of synthetic drugs is already surfacing in law enforcement reports.

Immediate Takeaway

If you have someone struggling with addiction, naloxone is now available over the counter and has proven effective. The policy debate about causation matters less than the reality that new synthetic drugs are being flagged by the government's own drug czar.